Showing results (1-10 of 800) with videos related to

Sort By:
Pageof 80
Journal of the National Comprehensive Cancer Network : JNCCN|September 25, 2009
New agents in chronic myelogenous leukemiaJorge Cortes, Francis Giles
Cancer Journal (Sudbury, Mass.)|November 23, 2007
Current perspectives on the treatment of patients with chronic myeloid leukemia: an individualized approach to treatmentElias Jabbour, Jorge Cortes, Francis Giles, et al.
Cancer|January 28, 2004
New agents in acute myeloid leukemia and other myeloid disordersFarhad Ravandi, Hagop Kantarjian, Francis Giles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Important therapeutic targets in chronic myelogenous leukemiaHagop M Kantarjian, Francis Giles, Alfonso Quintás-Cardama, et al.
Idrugs : the Investigational Drugs Journal|July 21, 2007
Drug evaluation: Nilotinib - a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of chronic myelocytic leukemia and beyondElias Jabbour, Jorge Cortes, Francis Giles, et al.
Seminars in Hematology|February 13, 2007
New targeted therapies for chronic myelogenous leukemia: opportunities to overcome imatinib resistanceElias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Annals of Internal Medicine|December 21, 2006
New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistanceHagop M Kantarjian, Moshe Talpaz, Francis Giles, et al.
Clinical Lymphoma & Myeloma|March 27, 2007
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challengesElias Jabbour, Jorge Cortes, Susan O'Brien, et al.
Leukemia Research|May 4, 2004
Interleukin 11 May improve thrombocytopenia associated with imatinib mesylate therapy in chronic Myelogenous leukemiaPatricia Ault, Hagop Kantarjian, Mary Alma Welch, et al.
Cancer|March 15, 2008
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulationsTai-Sung Lee, Steven J Potts, Hagop Kantarjian, et al.
Pageof 80